CN Stock MarketDetailed Quotes
002550 Changzhou Qianhong Biopharma
- 6.01
- -0.06-0.99%
Not Open Jan 3 15:00 CST
7.69BMarket Cap26.24P/E (TTM)
6.21High5.98Low152.58KlotVolume6.08Open6.07Pre Close93.08MTurnover1.68%Turnover Ratio42.32P/E (Static)1.28BShares7.1852wk High3.11P/B5.47BFloat Cap4.0852wk Low6.68Limit Up910.23MShs Float15.99Historical High5.46Limit Down3.79%Amplitude0.85Historical Low0.12Dividend TTM6.10Avg Price74.69KlotAsk2.00%Div YieldTTM100Lot Size75.40KlotBid
Changzhou Qianhong Biopharma Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -17.62%1.21B | -19.04%855.6M | -24.19%461.1M | -21.24%1.81B | -11.09%1.47B | -7.05%1.06B | 10.14%608.22M | 22.86%2.3B | 20.50%1.65B | 30.23%1.14B |
| Operating revenue | -17.62%1.21B | -19.04%855.6M | -24.19%461.1M | -21.24%1.81B | -11.09%1.47B | -7.05%1.06B | 10.14%608.22M | 22.86%2.3B | 20.50%1.65B | 30.23%1.14B |
| Other operating revenue | ---- | -70.17%995.45K | ---- | 358.99%5.17M | ---- | 126.10%3.34M | ---- | 10.02%1.13M | ---- | 189.36%1.48M |
| Total operating cost | -26.38%957.44M | -30.15%654.23M | -33.42%344.36M | -16.33%1.67B | -6.59%1.3B | -0.81%936.63M | 14.65%517.22M | 15.25%1.99B | 15.53%1.39B | 23.42%944.29M |
| Operating cost | -33.62%555.28M | -34.19%404.71M | -41.52%216.07M | -27.23%1.03B | -16.26%836.54M | -12.52%614.97M | 12.42%369.5M | 35.85%1.41B | 32.94%998.98M | 43.29%702.99M |
| Operating tax surcharges | 26.77%19.12M | 48.07%13.06M | 14.28%6.39M | 19.31%20.4M | 16.11%15.08M | -3.29%8.82M | -7.30%5.59M | -6.79%17.1M | 2.14%12.99M | 29.64%9.12M |
| Operating expense | -23.09%237.45M | -27.54%157.48M | -11.21%78.39M | -6.62%393.86M | -8.93%308.74M | 6.76%217.34M | 13.64%88.29M | -8.99%421.76M | 4.65%339M | 5.48%203.58M |
| Administration expense | -8.26%85.93M | -17.47%51.85M | 0.20%26.16M | 6.55%131.76M | 14.78%93.67M | 21.71%62.82M | 9.08%26.11M | -3.32%123.66M | -2.78%81.61M | -6.47%51.61M |
| Financial expense | 81.27%-1.26M | 42.92%-4.75M | -101.84%-131.26K | 91.38%-6.39M | 92.35%-6.74M | 84.38%-8.33M | 101.43%7.15M | -1,429.75%-74.2M | -703.53%-88.14M | -556.05%-53.33M |
| -Interest expense (Financial expense) | -78.83%1.17M | -74.87%982.02K | -55.98%726.67K | 13.22%5.93M | 34.73%5.54M | 34.62%3.91M | -12.51%1.65M | 215.73%5.23M | 192.62%4.11M | 278.29%2.9M |
| -Interest Income (Financial expense) | 27.09%-5.97M | -0.50%-6.21M | 50.95%-2.02M | -100.25%-11.3M | -105.66%-8.19M | -156.67%-6.18M | -428.96%-4.12M | -252.63%-5.64M | -4.70%-3.98M | -17.20%-2.41M |
| Research and development | 14.58%60.92M | -22.22%31.89M | -15.12%17.48M | 9.93%97.08M | 11.20%53.17M | 35.26%41M | 83.32%20.59M | 24.06%88.31M | 8.59%47.81M | 10.59%30.31M |
| Credit Impairment Loss | 392.54%81.94M | -142.83%-3.62M | -173.91%-6.06M | 215.42%17.43M | 250.15%16.64M | 164.11%8.45M | 190.02%8.21M | -128.80%-15.1M | -121.44%-11.08M | -1,241.54%-13.19M |
| Asset Impairment Loss | 3,671.19%49.65K | 3,671.19%49.65K | ---- | -3,685.29%-19.62M | ---1.39K | ---1.39K | ---1.39K | 4.27%-518.22K | ---- | --0 |
| Adjustment items of total operating cost | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- |
| Other net revenue | 235.47%96.81M | -78.09%3.19M | -97.67%262.25K | 17.75%56.13M | 320.08%28.86M | 186.84%14.56M | 254.18%11.24M | -23.31%47.67M | -124.54%-13.11M | -5,077.46%-16.76M |
| Fair value change income | 190.37%1.28M | 165.15%858.81K | 158.63%430.73K | 670.53%771.38K | 122.09%440.84K | -10.05%323.9K | -63.32%166.55K | -89.88%100.11K | 8.78%198.5K | 135.87%360.09K |
| Invest income | 41.46%5.16M | -41.87%549.37K | 972.47%3.03M | 270.72%8M | 143.66%3.65M | 112.33%945.07K | 127.73%282.36K | -1,244.58%-4.69M | -19.26%-8.35M | 4.60%-7.67M |
| Asset deal income | ---- | --0 | ---- | -55.98%25.35M | --208.74 | --0 | ---- | --57.59M | ---- | ---- |
| Other revenue | 3.02%8.38M | 10.67%5.35M | 10.95%2.87M | 135.25%24.2M | 32.99%8.14M | 29.65%4.84M | 8.15%2.59M | 6.76%10.28M | -28.62%6.12M | -47.21%3.73M |
| Operating profit | 78.54%346.97M | 51.88%204.55M | 14.45%117.01M | -43.24%204.36M | -20.18%194.34M | -23.40%134.68M | 8.97%102.23M | 71.97%360.01M | 12.35%243.46M | 62.45%175.83M |
| Add:Non operating Income | -94.72%1.35M | 688.36%1.12M | -98.63%1.83K | -52.01%350.92K | -56.69%25.5M | -99.76%141.92K | -99.77%133.89K | 79.92%731.23K | 14,884.84%58.89M | 18,480.51%58.58M |
| Less:Non operating expense | -41.92%619.46K | 254.59%231.2K | 1,636.66%174.4K | 190.70%1.18M | 174.83%1.07M | -78.49%65.2K | -93.47%10.04K | 10.96%407.28K | 15.18%388.05K | 32.25%303.18K |
| Total profit | 58.93%347.7M | 52.45%205.44M | 14.15%116.83M | -43.52%203.52M | -27.55%218.78M | -42.44%134.76M | -32.57%102.36M | 72.10%360.33M | 39.31%301.96M | 116.13%234.11M |
| Less:Income tax cost | 57.76%49.1M | 37.56%29.01M | -17.64%15.49M | -38.52%24.85M | -30.47%31.12M | -45.03%21.09M | -27.69%18.81M | 75.47%40.42M | 36.61%44.76M | 65.62%38.36M |
| Net profit | 59.12%298.6M | 55.21%176.43M | 21.30%101.35M | -44.15%178.67M | -27.04%187.65M | -41.93%113.67M | -33.58%83.55M | 71.68%319.91M | 39.79%257.2M | 129.87%195.75M |
| Net profit from continuing operation | 59.12%298.6M | 55.21%176.43M | 21.30%101.35M | -44.15%178.67M | -27.04%187.65M | -41.93%113.67M | -33.58%83.55M | 71.68%319.91M | 39.79%257.2M | 129.87%195.75M |
| Less:Minority Profit | -7.69%-10.99M | -18.84%-6.37M | -15.20%-2.76M | 8.99%-3.19M | 8.91%-10.2M | 12.35%-5.36M | 2.22%-2.4M | -166.56%-3.5M | -88.67%-11.2M | -53.03%-6.11M |
| Net profit of parent company owners | 56.47%309.59M | 53.57%182.79M | 21.13%104.11M | -43.77%181.86M | -26.28%197.86M | -41.03%119.03M | -32.98%85.95M | 78.60%323.41M | 41.32%268.4M | 126.42%201.86M |
| Earning per share | ||||||||||
| Basic earning per share | 59.52%0.2471 | 56.50%0.1457 | 23.07%0.0827 | -44.00%0.14 | -27.68%0.1549 | -42.35%0.0931 | -34.50%0.0672 | 66.67%0.25 | 40.74%0.2142 | 125.87%0.1615 |
| Diluted earning per share | 59.52%0.2471 | 56.50%0.1457 | 23.07%0.0827 | -44.00%0.14 | -27.68%0.1549 | -42.35%0.0931 | -34.50%0.0672 | 66.67%0.25 | 40.74%0.2142 | 125.87%0.1615 |
| Other composite income | 108.92%139.7K | -81.04%-741.72K | -2,850.69%-1.32M | 118.33%420.5K | 56.43%-1.57M | -159.64%-409.7K | -106.87%-44.83K | -173.72%-2.29M | -14,922.82%-3.59M | 4,878.38%687K |
| Other composite income of parent company owners | 108.92%139.7K | -81.04%-741.72K | -2,850.69%-1.32M | 118.33%420.5K | 56.43%-1.57M | -159.64%-409.7K | -106.87%-44.83K | -173.72%-2.29M | -14,922.82%-3.59M | 4,878.38%687K |
| Total composite income | 60.54%298.74M | 55.12%175.69M | 19.78%100.02M | -43.61%179.09M | -26.62%186.09M | -42.34%113.26M | -33.96%83.51M | 67.65%317.62M | 37.86%253.61M | 130.71%196.43M |
| Total composite income of parent company owners | 57.79%309.72M | 53.48%182.05M | 19.65%102.79M | -43.24%182.28M | -25.87%196.29M | -41.44%118.62M | -33.36%85.9M | 74.34%321.12M | 39.45%264.81M | 127.23%202.54M |
| Total composite income of minority owners | -7.69%-10.99M | -18.84%-6.37M | -15.20%-2.76M | 8.99%-3.19M | 8.91%-10.2M | 12.35%-5.36M | 2.22%-2.4M | -166.56%-3.5M | -88.67%-11.2M | -53.03%-6.11M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
